Gout

Fewer Side Effects With Naproxen vs Low-Dose Colchicine in Gout Flare Treatment

Researchers compared the effectiveness and safety of naproxen with low-dose colchicine in the treatment of gout flares in primary care.

Methylprednisolone Beneficial as Pre-Infusion Prophylaxis Therapy in Patients Receiving Pegloticase for Gout

Compared with intravenous hydrocortisone, IV methylprednisolone appears to be more beneficial as a pre-infusion prophylaxis therapy in patients receiving pegloticase, according to the findings of a recently published review.

Gout and Depression: Is There a Link?

In recent years, researchers have investigated a potential link between gout and depression. We review clinical evidence on the subject.

Gout Increases Risk for Kidney Transplant Complications, Return to Hemodialysis

Gout that develops in kidney transplant recipients increases their risk of worse outcomes, according to 2 new studies.

Lower Risk for Gout With SGLT2 Inhibitors vs GLP1 Agonists in Type 2 Diabetes

Researchers assessed the risk for gout among adults receiving a sodium-glucose cotransporter 2 inhibitor vs a glucagon-like peptide-1 receptor agonist.

Acute Myocardial Infarction Hospitalizations Occur at Younger Age in Gout, RA vs Osteoarthritis

Researchers assessed the demographics associated with the admission of acute myocardial infarction and evaluated the differences between rheumatoid arthritis and gout and osteoarthritis.

Gout May Be More Common Among Patients With Ankylosing Spondylitis Than General Population

Researchers compared the prevalence of gout in a population of patients with ankylosing spondylitis vs the general population.

Uncontrolled Gout Increases All-Cause, Cardiovascular Mortality

There is increasing evidence to support lower serum uric acid thresholds of at least 6 mg/dL in patients with gout to improve survival.

Global Annual Increase in Gout Burden Since 1990

Researchers analyzed data from the Global Burden of Disease Study on the burden of gout in 195 countries and territories between 1990 and 2017.

Addressing Physician Education to Improve Patient Outcomes in Gout

Dr Brian LaMoreaux emphasized the importance of screening, addressing manifestations, and physician education in improving patient outcomes in gout.